HEPATITIS B VIRUS TEST

This adverse event was reported 8 times

HEPATITIS B VIRUS TEST is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBRITUMOMAB TIUXETAN 1 0.0007
1 CHLORAMBUCIL 1 0.0003
2 MESALAMINE 1 0.0000
3 VINCRISTINE SULFATE 1 0.0000
4 IRBESARTAN 1 0.0000
5 ADALIMUMAB-FKJP 1 0.0000
6 ADALIMUMAB-AATY 1 0.0000
7 ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL 1 0.0000
8 ADALIMUMAB-ADAZ 1 0.0000
9 CYCLOPHOSPHAMIDE FOR INJECTION 3 0.0000
See all drugs enriched for association with HEPATITIS B VIRUS TEST

HEPATITIS B VIRUS TEST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkylating Drug [EPC] 4 0.0000
1 Topoisomerase Inhibitor [EPC] 1 0.0000
2 Aminosalicylate [EPC] 1 0.0000
3 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
4 Platinum-based Drug [EPC] 1 0.0000
5 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
6 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
7 Corticosteroid [EPC] 2 0.0000
See all drug classes enriched for association with HEPATITIS B VIRUS TEST